drug
as of 2026-07-01Apo-Methylphenidate ER
at a glance
small molecule
Pre-approval / investigational in the US
Developed by The Royal Ottawa Mental Health Centre
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes
NCT05414058Phase 2Completed
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here